Press Releases

oncology-analytics-publications-view-page-button-94x83 Oncology Analytics, Inc. Launches Comprehensive User-Friendly Clinical Decision Support Tool for Molecular & Genetic Testing

Guides Providers in Selecting Appropriate Test Choices Based on Clinical Utility

Oncology Analytics, Inc. Launches Comprehensive User-Friendly Clinical Decision Support Tool for Molecular & Genetic Testing Guides Providers in Selecting Appropriate Test Choices Based on Clinical Utility In response to the thousands of genetic and molecular tests being marketed, which consequently inundate health plans with reimbursement and policy coverage decisions, Oncology Analytics, Inc. has launched a clinical decision support tool for molecular and genetic testing that is simple and easy to use. Oncology Analytics, Inc., www.oncologyanalytics.com, is a comprehensive oncology benefits management company serving health plans, providers, and patients in the U.S. market and Puerto Rico. (more…)....Read more >>

oncology-analytics-publications-view-page-button-94x83 Oncology Analytics Reports 99% Adherence to Evidence-Based Treatment Protocols Based on 50,000 Cases

Approved Treatment Protocols Follow NCCN, CMS Guidelines, and Latest Scientific Findings

Oncology Analytics Reports 99% Adherence to Evidence-Based Treatment Protocols Based on 50,000 Cases Approved Treatment Protocols Follow NCCN, CMS Guidelines, and Latest Scientific Findings Oncology Analytics, Inc. reports today that an analysis of a years’ worth of its chemotherapy protocol data totaling more than 50,000 approved oncology cases ending June 2017 indicates that 98.64% of approved protocols were supported by a high level of scientific data. The company is continuously researching and updating its protocols based on the NCCN (National Comprehensive Cancer Network) Guidelines, CMS coverage criteria, including peer reviewed papers in any of the 26 journals approved by CMS, and other scientific data. (more…)....Read more >>

oncology-analytics-publications-view-page-button-94x83 Leading Benefits Manager Oncology Analytics, Inc. Aligned with New ASCO Policy Statement on Utilization Management

Oncology Analytics Assures High Quality Value-Based Cancer Drug Therapies

Oncology Analytics, Inc. Launches Comprehensive User-Friendly Clinical Decision Support Tool for Molecular & Genetic Testing Guides Providers in Selecting Appropriate Test Choices Based on Clinical Utility In response to the American Society of Clinical Oncology’s (ASCO) latest policy statement on the impact of utilization management for cancer drug therapies, Oncology Analytics, Inc. www.oncologyanalytics.com, a comprehensive oncology benefits management company serving health plans, providers, and patients in the U.S. market and Puerto Rico, (more…)....Read more >>

oncology-analytics-publications-view-page-button-94x83 Oncology Analytics’ Distinguished Academic Advisory Board Grows

New Members Bring Radiation Oncology and Pathology Expertise

Oncology Analytics' Distinguished Academic Advisory Board Grows New Members Bring Radiation Oncology and Pathology Expertise Oncology Analytics, Inc., today announced that it has added three new members to its Distinguished Academic Advisory Board. The three new board members include noted pathologist, Jonathan Epstein, MD, and key opinion leaders in radiation therapy, David Raben, MD, and Jay Harris, MD. (more…)....Read more >>

oncology-analytics-publications-view-page-button-94x83 Oncology Analytics Welcomes New Chief Medical Officer

Board-certified Radiation Oncologist to Spearhead Cancer Benefit Management Initiatives

Oncology Analytics Welcomes New Chief Medical Officer Board-certified Radiation Oncologist to Spearhead Cancer Benefit Management Initiatives This past June, Richard Wilder, MD, MBA, joined Oncology Analytics as its Chief Medical Officer. Recently, Dr. Wilder served for 2 ½ years as interim chair of the Department of Radiation Oncology at Moffitt Cancer Center in Tampa, Florida. (more…)....Read more >>

oncology-analytics-publications-view-page-button-94x83 Oncology Analytics Launches MATIS™ Clinical Decision Support Software

New Centralized and Comprehensive Web-based Application Improves Usability, Efficiency and Productivity in Cancer Care Benefit Management

Oncology Analytics Launches MATISTM Clinical Decision Support Software New Centralized and Comprehensive Web-based Application Improves Usability, Efficiency and Productivity in Cancer Care Benefit Management Oncology Analytics, Inc., today announced that its MATISTM clinical decision support software has launched, and is actively in use with health care plans and providers throughout the U.S. and Puerto Rico. MATISTM is designed to enhance Oncology Analytics’ evidence-based approach to the evaluation of cancer treatment and benefits management. (more…)....Read more >>